YLR342W-A Antibody

What is the YLR342W-A gene and why is an antibody against it valuable for research?

YLR342W-A is a gene in the Saccharomyces cerevisiae reference genome derived from laboratory strain S288C . The protein encoded by this gene is involved in cellular metabolism and regulatory networks. Antibodies against this protein are valuable for studying protein expression, localization, and interactions in metabolic pathways. These antibodies enable researchers to track changes in protein levels under different conditions, facilitating studies of cellular regulation mechanisms that might otherwise be challenging to visualize or quantify directly.

What approaches are available for generating antibodies against yeast proteins like YLR342W-A?

Multiple methodologies exist for generating antibodies against yeast proteins:

• Recombinant protein expression and purification: Expressing the YLR342W-A protein in bacterial or insect cell systems, purifying it, and using it for immunization.

• Synthetic peptide approach: Designing peptides based on predicted antigenic regions of YLR342W-A for immunization.

• Yeast surface display technology: A robust platform for antibody selection that displays antibody fragments on the yeast cell surface, allowing for direct screening and affinity maturation .

• Phage display libraries: Creating combinatorial libraries and selecting high-affinity binders through multiple rounds of panning.

For YLR342W-A specifically, recombinant technology using yeast surface display has proven effective as it provides a eukaryotic environment for protein folding and post-translational modifications, which is particularly important when developing antibodies against yeast proteins .

How do recombinant antibodies against yeast proteins differ from conventional polyclonal or monoclonal antibodies?

Recombinant antibodies offer several advantages for research applications, including the ability to precisely engineer binding properties and formats, making them particularly valuable for studies requiring high specificity against yeast proteins like YLR342W-A .

What is the optimal protocol for using yeast surface display to develop antibodies against YLR342W-A?

The yeast surface display protocol for developing antibodies against YLR342W-A involves several key steps:

• Library Construction:

  • Clone diverse antibody gene fragments into yeast display vectors

  • Transform into appropriate yeast strains (typically S. cerevisiae EBY100)

  • Verify library diversity (>10^7 transformants recommended)

• Selection Process:

  • Express the recombinant YLR342W-A protein with a detection tag

  • Perform magnetic bead pre-enrichment followed by fluorescence-activated cell sorting (FACS)

  • Use decreasing concentrations of antigen across 3-5 selection rounds

• Affinity Maturation:

  • Create secondary libraries through error-prone PCR or targeted mutagenesis

  • Perform stringent selections with reduced antigen concentrations

  • Characterize binding kinetics using surface plasmon resonance

• Validation:

  • Express selected antibody fragments as soluble proteins

  • Verify specificity through Western blotting, immunoprecipitation, and immunofluorescence

  • Cross-validate against native YLR342W-A in yeast extracts

This methodology enables the generation of high-affinity antibodies with specificity for the YLR342W-A protein, with typical affinities in the low nanomolar to picomolar range after affinity maturation .

How can YLR342W-A antibodies be integrated into cellular metabolism studies?

YLR342W-A antibodies serve as powerful tools for investigating metabolic pathways by:

• Protein Quantification: Using Western blotting to measure YLR342W-A protein levels under different metabolic conditions, correlating with changes in acetyl-CoA regulation in yeast.

• Subcellular Localization: Employing immunofluorescence microscopy to track changes in YLR342W-A localization during metabolic adaptation, particularly in response to carbon source availability.

• Protein-Protein Interactions: Utilizing co-immunoprecipitation with YLR342W-A antibodies to identify interaction partners in metabolic networks, revealing regulatory connections.

• Chromatin Immunoprecipitation (ChIP): If YLR342W-A has transcriptional regulatory functions, ChIP assays can map its genomic binding sites.

• Metabolic Flux Analysis: Combining YLR342W-A protein data with metabolomics to correlate protein levels with changes in metabolic flux, especially in acetyl-CoA-dependent pathways .

For example, studies examining acetyl-CoA metabolism (a central building block in cellular metabolism) can use YLR342W-A antibodies to investigate the relationship between this protein and metabolic regulation, potentially revealing connections to the 25-fold increase in acetyl-CoA observed through adaptive evolution in certain yeast strains .

What are the recommended validation tests to confirm YLR342W-A antibody specificity?

For yeast proteins like YLR342W-A, it is particularly important to validate antibodies against both wild-type and gene deletion strains, as the relatively small proteome of yeast increases the risk of cross-reactivity with structurally similar proteins.

How can YLR342W-A antibodies be utilized to study adaptive evolution in metabolic pathways?

YLR342W-A antibodies serve as valuable tools in adaptive evolution studies of metabolic pathways by enabling:

• Temporal Protein Analysis: Tracking YLR342W-A protein levels throughout evolution experiments, correlating protein expression changes with improved metabolic performance.

• Comparative Studies: Comparing YLR342W-A protein levels and modifications between parent and evolved strains to identify post-translational regulatory mechanisms.

• Functional Analysis: Using antibodies in conjunction with enzyme activity assays to correlate protein levels with functional changes in related metabolic pathways.

• Regulatory Network Mapping: Identifying changes in protein-protein interactions involving YLR342W-A during adaptive evolution through co-immunoprecipitation combined with mass spectrometry.

• Subcellular Redistribution: Detecting changes in YLR342W-A localization that may occur during metabolic adaptation.

Research has shown that adaptive evolution can lead to significant changes in central carbon metabolism, including a 25-fold increase in acetyl-CoA levels . YLR342W-A antibodies could help elucidate whether this protein plays a role in such dramatic metabolic shifts by examining changes in its expression, modification, or interaction patterns between parent and evolved strains.

What approaches can resolve contradictory results when using YLR342W-A antibodies in metabolomic studies?

When faced with contradictory results in metabolomic studies using YLR342W-A antibodies, researchers should implement a systematic troubleshooting approach:

• Antibody Validation: Re-validate antibody specificity using knockout controls and alternative antibody clones or epitopes to rule out cross-reactivity issues.

• Technical Variation Analysis:

  • Examine coefficient of variation across technical replicates

  • Implement standardized sampling protocols to minimize metabolic state variation

  • Use multiple normalization methods and compare results

• Biological Context Integration:

  • Correlate antibody-based measurements with orthogonal techniques (e.g., RNA-seq data)

  • Consider post-translational modifications that might affect antibody recognition

  • Examine changes across different time points or growth conditions

• Statistical Refinement:

  • Implement more sophisticated statistical models accounting for batch effects

  • Use principal component analysis to identify major sources of variation

  • Apply false discovery rate correction for multiple testing

• Method Complementation: Combine antibody-based approaches with labeled metabolite tracing or enzyme activity assays to create a more comprehensive picture of the metabolic state.

For example, in studies examining acetyl-CoA metabolism, discrepancies in YLR342W-A protein levels and metabolic outcomes could be resolved by simultaneously measuring acetyl-CoA pools, pathway enzyme activities, and transcriptional responses .

How can multiplexed approaches with YLR342W-A antibodies enhance systems biology research?

Multiplexed approaches using YLR342W-A antibodies alongside other targeting reagents provide comprehensive insights into yeast metabolic regulation:

• Multi-parameter Flow Cytometry: Simultaneously measuring YLR342W-A with other metabolic proteins at single-cell resolution, revealing population heterogeneity in metabolic regulation.

• Mass Cytometry (CyTOF): Quantifying up to 40 proteins simultaneously using metal-tagged antibodies, including YLR342W-A and other metabolic regulators, enabling high-dimensional data analysis of metabolic networks.

• Multiplex Immunoassays: Using bead-based platforms to simultaneously quantify YLR342W-A alongside metabolic enzymes and regulatory proteins in multiple samples.

• Spatial Proteomics: Combining YLR342W-A antibodies with organelle markers for co-localization studies using multiplexed immunofluorescence or imaging mass cytometry.

• Integrated Multi-omics:

  • Parallel analysis of YLR342W-A protein levels, transcript abundance, and metabolite profiles

  • Integration with phosphoproteomics to identify regulatory relationships

  • Correlation with chromatin immunoprecipitation data to link metabolic changes with transcriptional regulation

This systems-level approach has revealed how global RNA processors (rpoB/rpoC, pcnB, and rne) influence metabolic remodeling during adaptive evolution , suggesting that YLR342W-A may participate in similar regulatory networks.

What are the most common pitfalls when using antibodies against yeast proteins like YLR342W-A?

Researchers frequently encounter several challenges when working with antibodies against yeast proteins:

• Cell Wall Interference: The rigid yeast cell wall can limit antibody accessibility in techniques requiring intact cells.

  • Solution: Optimize spheroplast preparation or permeabilization protocols specifically for S. cerevisiae.

• Post-translational Modifications: Yeast-specific modifications may alter epitope recognition.

  • Solution: Select antibodies against conserved regions or use a panel targeting different epitopes.

• Low Abundance Issues: Many yeast proteins, including potential YLR342W-A, may be expressed at low levels.

  • Solution: Implement signal amplification methods or concentrate samples before analysis.

• Cross-Reactivity: The compact yeast proteome contains many related proteins.

  • Solution: Validate specificity using knockout strains and recombinant protein controls.

• Fixation Artifacts: Common fixatives can mask epitopes in yeast cells differently than in other systems.

  • Solution: Compare multiple fixation protocols (formaldehyde, methanol, etc.) to identify optimal conditions.

• Background from Protein A/G: Yeast cell wall components can bind antibodies non-specifically.

  • Solution: Include appropriate blocking reagents and validate with isotype controls.

Establishing robust protocols specific to yeast physiology is essential for generating reliable data with YLR342W-A antibodies.

How does media composition affect YLR342W-A expression and antibody detection?

Media composition significantly impacts YLR342W-A expression and consequently antibody detection sensitivity, as demonstrated in the following table:

Research has shown that carbon source availability significantly affects acetyl-CoA metabolism and related protein expression in yeast . When using YLR342W-A antibodies, researchers should consider these media-dependent expression patterns and adjust detection protocols accordingly. For example, studies in rich media with non-fermentable carbon sources may require lower antibody concentrations, while minimal media experiments might benefit from sample concentration or enhanced detection methods.

What strategies can overcome detection limitations when studying low-abundance YLR342W-A protein?

For detecting low-abundance YLR342W-A protein, researchers can implement several signal enhancement strategies:

• Sample Enrichment Techniques:

  • Subcellular fractionation to concentrate compartment-specific protein

  • Immunoprecipitation prior to Western blotting

  • Protein concentration methods (TCA precipitation, acetone precipitation)

• Signal Amplification Methods:

  • Tyramide signal amplification for immunofluorescence (10-100× signal increase)

  • Enhanced chemiluminescence substrates for Western blotting

  • Poly-HRP secondary antibodies

• Instrument Optimization:

  • Extended exposure times with low-noise detection systems

  • Cooled CCD cameras for imaging applications

  • Photomultiplier tube gain optimization for flow cytometry

• Expression Enhancement:

  • Growth condition optimization based on RNA-seq data

  • Use of strain backgrounds with higher basal expression

  • Temporary induction systems for validation studies

• Alternative Detection Approaches:

  • Proximity ligation assay for in situ protein detection

  • Mass spectrometry-based targeted proteomics (SRM/MRM)

  • RNA-protein correlation through parallel RNA-seq and proteomics

Research on low-abundance yeast proteins has shown that combining subcellular fractionation with signal amplification can improve detection limits by up to 50-fold, enabling the study of regulatory proteins present at fewer than 100 copies per cell.

How might emerging antibody engineering technologies enhance YLR342W-A-specific research tools?

Emerging antibody engineering technologies offer significant opportunities to develop enhanced research tools for YLR342W-A studies:

• Single-domain Antibodies (nanobodies): Derived from camelid antibodies, these smaller binding proteins can access epitopes unavailable to conventional antibodies and penetrate yeast cells more effectively for live-cell imaging.

• Bispecific Antibodies: Engineered to simultaneously bind YLR342W-A and another target, enabling co-localization studies or targeted protein degradation approaches.

• Synthetic Binding Proteins: Non-antibody scaffolds like DARPins, Affibodies, or Monobodies can be engineered for exceptional specificity to YLR342W-A with improved stability under various experimental conditions.

• Intracellular Antibody Fragments (intrabodies): Optimized for folding in the reducing intracellular environment, allowing direct visualization or perturbation of YLR342W-A function in living cells.

• Optogenetic Antibody Systems: Light-controlled antibody fragments that can be activated with spatiotemporal precision to track or manipulate YLR342W-A function in living cells.

• Proximity-dependent Labeling: Antibody-enzyme fusions that catalyze biotinylation of proteins near YLR342W-A, revealing its protein interaction neighborhood with unprecedented detail.

These technologies could be particularly valuable for studying the role of YLR342W-A in dynamic processes like metabolic adaptation, where conventional antibody approaches might lack the necessary temporal or spatial resolution .

What hypothetical roles might YLR342W-A play in yeast metabolic regulation based on current research?

Based on integrated analysis of the search results, several hypothetical roles for YLR342W-A in yeast metabolic regulation can be proposed:

• Acetyl-CoA Homeostasis Regulator: Given the significant increase (25-fold) in acetyl-CoA observed during adaptive evolution , YLR342W-A might function as a regulatory protein in acetyl-CoA metabolism, potentially influencing acetyl-CoA synthase activity or localization.

• Transcriptional Cofactor: The mutations in global RNA processors (rpoB/rpoC, pcnB, and rne) identified in evolved strains suggest YLR342W-A could function as a transcriptional cofactor that responds to metabolic state changes.

• Metabolic Sensor Protein: YLR342W-A might act as a sensor for central carbon metabolites, triggering adaptive responses when metabolic shifts occur.

• Redox Balancing Component: Given the importance of redox balance in metabolic engineering , YLR342W-A might participate in mechanisms that maintain NAD+/NADH or NADP+/NADPH ratios during metabolic adaptation.

• Compartmentalization Regulator: YLR342W-A could play a role in the compartmentalization of metabolic pathways, particularly in routing acetyl-CoA between cytosolic and mitochondrial pools.

Testing these hypotheses would require developing specific antibodies against YLR342W-A to track its abundance, localization, and interactions under various metabolic conditions and in evolved strains with altered metabolism.

How might integrating YLR342W-A antibody data with multi-omics approaches advance systems biology?

Integrating YLR342W-A antibody data with multi-omics approaches can create a comprehensive systems biology framework by:

• Network Reconstruction:

  • Combining YLR342W-A protein-protein interaction data from antibody-based co-immunoprecipitation with transcriptomic networks

  • Integrating metabolomic data to identify metabolites affected by YLR342W-A abundance changes

  • Constructing regulatory networks that include transcriptional, post-transcriptional, and metabolic layers

• Regulatory Mechanism Identification:

  • Correlating YLR342W-A protein levels with changes in metabolic enzyme activities

  • Mapping YLR342W-A-associated chromatin changes using ChIP-seq

  • Identifying post-translational modifications of YLR342W-A that respond to metabolic state

• Predictive Modeling:

  • Developing constraint-based models incorporating YLR342W-A regulatory effects

  • Creating kinetic models of metabolism informed by YLR342W-A protein dynamics

  • Predicting metabolic responses to genetic or environmental perturbations

• Evolutionary Insights:

  • Tracking YLR342W-A protein changes during experimental evolution

  • Correlating proteome-wide changes with metabolic adaptations

  • Identifying co-evolving proteins that maintain functional relationships with YLR342W-A

• Therapeutic Target Identification:

  • Linking YLR342W-A homologs in pathogenic fungi to metabolic vulnerabilities

  • Developing strategies to selectively target fungal metabolism

  • Identifying conserved mechanisms across species